NTRA Natera, Inc.
Nasdaq · SEC CIK 1604821 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $383.05M 135 sales by 12 insiders
- Filings on record
- 783 since 2021-07-07, latest 2026-09-25 21:35
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE COB, Dir | — | $124.05M |
| Chapman Steven Leonard | CEO AND Pres, Dir | — | $93.95M |
| BOTHA ROELOF | Dir | — | $34.89M |
| Sheena Jonathan | Dir, CO-FOUNDER | — | $29.84M |
| RABINOWITZ DANIEL | SEC. AND CLO | — | $23.83M |
| Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | — | $22.88M |
| Brophy Michael Burkes | CFO | — | $22.14M |
| ROSENMAN HERM | Dir | — | $15.14M |
| Fesko John | Pres, CHIEF BUS. Off | — | $9.35M |
| Baynes Roy D. | Dir | — | $2.81M |
Transactions 1,059
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-22 | 2025-04-20 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +190 | 255.4K | +0.1% | — |
| M | 2025-04-22 | 2025-04-21 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $145.56 | -296 | 141.5K | -0.2% | -$43.1K |
| DM | 2025-04-22 | 2025-04-21 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $145.55 | -610 | 76.5K | -0.8% | -$88.8K |
| D | 2025-04-22 | 2025-04-20 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,521 | 77.1K | +2% | — |
| M | 2025-04-22 | 2025-04-21 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $145.55 | -343 | 156.9K | -0.2% | -$49.9K |
| DM | 2025-04-22 | 2025-04-21 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $145.55 | -1,664 | 198.4K | -0.8% | -$242.2K |
| D | 2025-04-22 | 2025-04-20 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +3,386 | 200.0K | +2% | — |
| D | 2025-04-22 | 2025-04-20 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +856 | 226.1K | +0.4% | — |
| DM | 2025-04-22 | 2025-04-21 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $145.55 | -470 | 225.7K | -0.2% | -$68.4K |
| M | 2025-04-04 | 2025-04-04 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $133.14 | -3,070 | 255.3K | -1% | -$408.8K |
| MI | 2025-04-04 | 2025-04-03 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $139.19 | -3,000 | 40.3K | -7% | -$417.6K |
| M | 2025-04-03 | 2025-04-01 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $140.48 | -3,000 | 143.5K | -2% | -$421.4K |
| DM | 2025-04-03 | 2025-04-01 | NTRA | Marcus Gail Boxer | Dir | M - OptEx | $19.74 | +4,000 | 10.8K | +59% | +$79.0K |
| DM | 2025-04-03 | 2025-04-01 | NTRA | Marcus Gail Boxer | Dir | S - Sale+OE | $140.77 | -4,000 | 11.8K | -25% | -$563.1K |
| D | 2025-04-01 | 2025-03-28 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +2,500 | 226.7K | +1% | — |
| DM | 2025-04-01 | 2025-03-31 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $138.41 | -1,404 | 225.3K | -0.6% | -$194.3K |
| DM | 2025-04-01 | 2025-03-31+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $139.70 | -25.5K | 202.0K | -11% | -$3.56M |
| D | 2025-04-01 | 2025-03-28 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +18.8K | 222.1K | +9% | — |
| DM | 2025-04-01 | 2025-03-31 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $138.41 | -2,562 | 75.6K | -3% | -$354.6K |
| D | 2025-04-01 | 2025-03-28 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +6,250 | 78.1K | +9% | — |
| 2025-04-01 | 2025-03-28 | NTRA | Bertagnolli Monica | Dir | A - Grant | — | +2,877 | 2,877 | New | — | |
| M | 2025-03-19 | 2025-03-17 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $146.04 | -795 | 157.3K | -0.5% | -$116.1K |
| M | 2025-03-19 | 2025-03-17 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $146.04 | -1,026 | 144.8K | -0.7% | -$149.8K |
| 2025-03-19 | 2025-03-17 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $146.03 | -6,702 | 203.4K | -3% | -$978.7K | |
| M | 2025-03-19 | 2025-03-17 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $146.04 | -928 | 224.2K | -0.4% | -$135.5K |
| M | 2025-03-19 | 2025-03-17 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $146.04 | -792 | 71.9K | -1% | -$115.7K |
| M | 2025-03-19 | 2025-03-17 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $146.04 | -1,127 | 2.36M | -0.0% | -$164.6K |
| MI | 2025-03-19 | 2025-03-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $145.65 | -3,000 | 42.2K | -7% | -$436.9K |
| M | 2025-03-19 | 2025-03-17+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $145.59 | -2,881 | 259.0K | -1% | -$419.4K |
| 2025-03-14 | 2025-03-12 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +1,740 | 225.1K | +0.8% | — | |
| 2025-03-14 | 2025-03-12 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +2,040 | 145.8K | +1% | — | |
| 2025-03-14 | 2025-03-12 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +6,702 | 210.1K | +3% | — | |
| DM | 2025-03-14 | 2025-03-12 | NTRA | Marcus Gail Boxer | Dir | S - Sale+OE | $147.69 | -4,000 | 9,704 | -29% | -$590.8K |
| D | 2025-03-14 | 2025-03-12 | NTRA | Marcus Gail Boxer | Dir | M - OptEx | $7.86 | +4,000 | 13.7K | +41% | +$31.4K |
| 2025-03-14 | 2025-03-12 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +2,040 | 158.1K | +1% | — | |
| 2025-03-14 | 2025-03-12 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +411 | 261.2K | +0.2% | — | |
| 2025-03-14 | 2025-03-12 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +2,032 | 72.7K | +3% | — | |
| M | 2025-03-14 | 2025-03-14 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $147.71 | -50.0K | 2.41M | -2% | -$7.39M |
| 2025-03-14 | 2025-03-12 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | A - Grant | — | +2,893 | 2.42M | +0.1% | — | |
| M | 2025-03-07 | 2025-03-05 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $143.40 | -87.3K | 214.6K | -29% | -$12.52M |
| M | 2025-03-07 | 2025-03-05 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $143.29 | -6,000 | 148.6K | -4% | -$859.7K |
| M | 2025-02-28 | 2025-02-26 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $160.54 | -2,700 | 263.4K | -1% | -$433.5K |
| MI | 2025-02-28 | 2025-02-26 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $160.47 | -3,000 | 43.3K | -6% | -$481.4K |
| 2025-02-07 | 2025-02-06 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $177.77 | -1,632 | 149.8K | -1% | -$290.1K | |
| M | 2025-02-07 | 2025-02-05 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +3,197 | 149.9K | +2% | — |
| 2025-02-07 | 2025-02-05 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +1,675 | 156.7K | +1% | — | |
| 2025-02-07 | 2025-02-06 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $177.77 | -663 | 156.0K | -0.4% | -$117.9K | |
| 2025-02-04 | 2025-01-31 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +36.7K | 290.6K | +14% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | A - Grant | — | +29.3K | 2.41M | +1% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +10.4K | 223.4K | +5% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +12.7K | 148.2K | +9% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +12.7K | 114.5K | +12% | — | |
| M | 2025-02-04 | 2025-01-31+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $176.85 | -43.9K | 110.6K | -28% | -$7.76M |
| 2025-02-04 | 2025-01-31 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +3,549 | 263.5K | +1% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | BOTHA ROELOF | Dir | A - Grant | — | +151 | 3,918 | +4% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Baynes Roy D. | Dir | A - Grant | — | +92 | 15.9K | +0.6% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | HEALY JAMES | Dir | A - Grant | — | +114 | 46.1K | +0.2% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +11.8K | 155.0K | +8% | — | |
| 2025-02-04 | 2025-01-31 | NTRA | ROSENMAN HERM | Dir | A - Grant | — | +133 | 65.9K | +0.2% | — | |
| M | 2025-01-31 | 2025-01-29 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $165.87 | -4,030 | 143.2K | -3% | -$668.5K |
| M | 2025-01-31 | 2025-01-29 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $165.87 | -4,773 | 216.8K | -2% | -$791.7K |
| M | 2025-01-31 | 2025-01-29 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale | $165.87 | -13.7K | 263.8K | -5% | -$2.27M |
| M | 2025-01-31 | 2025-01-29+ | NTRA | Brophy Michael Burkes | CFO | S - Sale | $169.12 | -6,221 | 103.7K | -6% | -$1.05M |
| M | 2025-01-31 | 2025-01-29 | NTRA | Rabinowitz Matthew | EXECUTIVE COB, Dir | S - Sale | $165.87 | -6,003 | 2.38M | -0.3% | -$995.7K |
| M | 2025-01-31 | 2025-01-29+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $167.31 | -1,217 | 259.9K | -0.5% | -$203.6K |
| M | 2025-01-31 | 2025-01-29 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $165.87 | -5,201 | 135.5K | -4% | -$862.7K |
| 2025-01-29 | 2025-01-27 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | G - Gift | $0.00 | -588 | 261.2K | -0.2% | $0 | |
| 2025-01-29 | 2025-01-27 | NTRA | Brophy Michael Burkes | CFO | S - Sale | $161.87 | -1,442 | 108.0K | -1% | -$233.4K | |
| D | 2025-01-24 | 2025-01-22 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +1,250 | 110.9K | +1% | — |
| DM | 2025-01-24 | 2025-01-23+ | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $171.67 | -1,441 | 109.5K | -1% | -$247.4K |
| M | 2025-01-24 | 2025-01-22 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $164.97 | -24.9K | 140.7K | -15% | -$4.10M |
| M | 2025-01-24 | 2025-01-22 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $164.97 | -21.2K | 147.3K | -13% | -$3.50M |
| DM | 2025-01-22 | 2025-01-20+ | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +5,161 | 346.2K | +2% | — |
| DM | 2025-01-22 | 2025-01-22 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $164.97 | -78.6K | 267.6K | -23% | -$12.96M |
| DM | 2025-01-22 | 2025-01-22 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $165.00 | -971 | 261.8K | -0.4% | -$160.2K |
| DM | 2025-01-22 | 2025-01-20+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +335 | 262.6K | +0.1% | — |
| DM | 2025-01-22 | 2025-01-20+ | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +2,667 | 135.6K | +2% | — |
| DM | 2025-01-22 | 2025-01-22 | NTRA | Brophy Michael Burkes | CFO | S - Sale+OE | $164.97 | -25.9K | 109.7K | -19% | -$4.28M |
| DM | 2025-01-22 | 2025-01-22 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale+OE | $164.97 | -22.0K | 217.8K | -9% | -$3.64M |
| DM | 2025-01-22 | 2025-01-20+ | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +1,500 | 239.2K | +0.6% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Brophy Michael Burkes | CFO | M - OptEx | — | +24.3K | 93.2K | +35% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Brophy Michael Burkes | CFO | A - Grant | — | +39.7K | 132.9K | +43% | — |
| M | 2025-01-21 | 2025-01-16 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +48.5K | 165.5K | +41% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | A - Grant | — | +4,966 | 262.4K | +2% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | — | +3,043 | 257.4K | +1% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | A - Grant | — | +101.8K | 341.0K | +43% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | — | +54.2K | 239.2K | +29% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | A - Grant | — | +24.8K | 238.3K | +12% | — |
| D | 2025-01-21 | 2025-01-16 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | M - OptEx | — | +13.7K | 213.5K | +7% | — |
| M | 2025-01-21 | 2025-01-16 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +54.3K | 127.8K | +74% | — |
| 2025-01-10 | 2025-01-08 | NTRA | RABINOWITZ DANIEL | SEC. AND CLO | S - Sale | $175.30 | -6,223 | 199.8K | -3% | -$1.09M | |
| M | 2025-01-03 | 2025-01-02 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $159.44 | -2,700 | 255.8K | -1% | -$430.5K |
| MI | 2025-01-03 | 2025-01-02 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $159.55 | -3,000 | 45.6K | -6% | -$478.6K |
| M | 2024-12-26 | 2024-12-20 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | A - Grant | — | +4,719 | 116.4K | +4% | — |
| M | 2024-12-26 | 2024-12-23 | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.60 | -2,428 | 119.4K | -2% | -$387.5K |
| 2024-12-26 | 2024-12-20 | NTRA | Fesko John | Pres, CHIEF BUS. Off | A - Grant | — | +1,675 | 114.8K | +1% | — | |
| M | 2024-12-26 | 2024-12-23 | NTRA | Fesko John | Pres, CHIEF BUS. Off | S - Sale | $159.60 | -669 | 114.1K | -0.6% | -$106.8K |
| M | 2024-12-23 | 2024-12-19+ | NTRA | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | G - Gift | $0.00 | -206 | 114.7K | -0.2% | $0 |
| M | 2024-12-20 | 2024-12-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $167.27 | -2,700 | 259.4K | -1% | -$451.6K |
| MI | 2024-12-20 | 2024-12-18 | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale | $167.24 | -3,000 | 46.3K | -6% | -$501.7K |
Purchase Sale Sale after option exercise All abbreviations